Kazia Therapeutics
IPOKazia Therapeutics, ASX: KZA, biotechnology
Public · Sydney, Australia · Founded 2016
- Headquarters
- Sydney
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- kaziatherapeutics.com
- Type
- Public
About
Kazia Therapeutics is an Australian oncology company developing innovative cancer drugs, with its lead program paxalisib targeting brain tumors.
Summary
Kazia Therapeutics is a Biotech company based in Sydney, Australia, founded in 2016.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...